• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

BlackRock Health Sciences Opportunities Portfolio

+ Add to Watchlist

SHSCX:US

46.42 USD 0.28 0.61%

As of 09:29:30 ET on 12/19/2014.

Snapshot for BlackRock Health Sciences Opportunities Portfolio (SHSCX)

Year To Date: +31.37% 3-Month: +10.83% 3-Year: +31.84% 52-Week Range: 34.91 - 46.42
1-Month: +4.34% 1-Year: +34.25% 5-Year: +20.00% Beta vs SPX: 0.99

Mutual Fund Chart for SHSCX

No chart data available.
  • SHSCX:US 46.42
  • 1M
  • 1Y
Interactive SHSCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SHSCX

BlackRock Health Sciences Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective is long-term growth of capital. The Fund normally invests at least 80% of total assets in securities of companies in health sciences and related industries.

Inception Date: 12-21-1999 Telephone: 1-800-441-7762
Managers: THOMAS P CALLAN / H ERIN XIE
Web Site: www.blackrock.com

Fundamentals for SHSCX

NAV (on 2014-12-19) 46.42
Assets (M) (on 2014-12-19) 4,883.73
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for SHSCX

No dividends reported

Fees & Expenses for SHSCX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.72
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.91

Top Fund Holdings for SHSCX

Filing Date: 10/31/2014
Name Position Value % of Total
Celgene Corp 1,371,638 146,888,713 3.265%
AbbVie Inc 2,198,900 139,542,194 3.102%
Amgen Inc 841,110 136,411,220 3.032%
Alexion Pharmaceuticals Inc 699,617 133,878,709 2.976%
Merck & Co Inc 2,235,500 129,524,870 2.879%
Biogen Idec Inc 400,600 128,624,648 2.859%
Johnson & Johnson 1,141,300 123,009,314 2.735%
UnitedHealth Group Inc 1,250,782 118,836,798 2.642%
BlackRock Liquidity Funds Temp 106,272,064 106,272,064 2.362%
Novartis AG 1,126,500 104,542,436 2.324%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil